We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 1,233 results

  1. Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

    Introduction

    Talquetamab, a bispecific antibody targeting GPRC5D × CD3, is approved for the treatment of patients with triple-class -exposed (TCE)...

    Hermann Einsele, Philippe Moreau, ... Maria-Victoria Mateos in Advances in Therapy
    Article Open access 24 February 2024

  2. Talquetamab: First Approval

    Talquetamab (talquetamab-tgvs; TALVEY ® ), a humanized, bispecific G-protein coupled receptor family C group 5 member D (GPRC5D)-directed CD3 T-cell...

    Susan J. Keam in Drugs
    Article 04 October 2023

  3. A randomized control trial to support smoke-free policy compliance in public housing

    Background

    Smoke-free housing policies in multiunit housing are increasingly widespread interventions to reduce smoking and secondhand smoke exposure....

    Diana Hernandez, Farzana Khan, ... Ana Navas-Acien in Trials
    Article Open access 22 August 2023

  4. Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab

    Purpose

    In recent years, various immunotherapies have improved the survival of patients with multiple myeloma (MM). However, there remains an unmet...

    A. M. G. A. Laheij, N. W. C. J. van de Donk in Supportive Care in Cancer
    Article 14 December 2023

  5. Otorhinolaryngology as “Made in Germany” since 1921: an international perspective

    In 2021, the German Society of Otorhinolaryngology, Head Neck Surgery celebrates the 100th anniversary of its foundation. The aim of this research is...

    Albert Mudry in HNO
    Article 16 April 2021

  7. Governance models for historical hospitals: evidence from Italy

    Many hospitals and health care organizations over the centuries have inherited handcrafts of artistic value, objects of worships, donations from...

    Martina Giusti, Ilaria Elisa Vannini, Niccolò Persiani in BMC Health Services Research
    Article Open access 06 March 2024

  9. Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting

    Several bispecific antibodies (bsAbs) targeting BCMA, GPRC5D, and FcRH5 are in clinical trials for heavily pretreated multiple myeloma (MM) patients....

    Juanjuan Zhao, Quan Ren, ... Yong** Song in Journal of Hematology & Oncology
    Article Open access 03 August 2023

  10. Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting

    B cell maturation antigen (BCMA)-targeted immunotherapy has shown unprecedented results in the treatment of relapsed or refractory (R/R) multiple...

    Jieyun **a, Zhenyu Li, Kailin Xu in Journal of Hematology & Oncology
    Article Open access 05 June 2023

  15. Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents

    Multiple Myeloma remains incurable, and there is a need for therapies with novel mechanisms of action. Recently, B cell maturation antigen targeted...

    Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda in Cancer Immunology, Immunotherapy
    Article Open access 04 November 2023
Did you find what you were looking for? Share feedback.